Entecavir is recommended for the initial treatment of hepatitis B patients because it can not only control transaminase elevation but also has fewer adverse effects than tenofovir disoproxil fumarate tablets.
Entecavir not only has the effect of inhibiting the elevation of aminotransferases, but also has relatively fewer adverse effects and is safer for long-term use, so as long as the patient does not develop resistance and allergic reactions to entecavir, it is recommended to give preference to entecavir. The adverse effects of entecavir include nausea, headache, fatigue and dizziness, etc. It is contraindicated for those who are allergic to entecavir.
Adverse effects of tenofovir disoproxil fumarate tablets include nausea, dizziness, diarrhea and rash, etc. Tenofovir disoproxil fumarate tablets are contraindicated for those who are allergic to tenofovir disoproxil fumarate.
In addition, the application of the above drugs has certain risks, patients need to get the guidance of a specialist, not blindly use their own medication.